Oorsprong van het eerstegraads netwerk van Michael H. Golden
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada.
18
| Subsidiary | Pharmaceuticals: Major | 18 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Michael H. Golden via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CDI CORP. | Personnel Services | Director/Board Member | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SAFEGUARD SCIENTIFICS, INC. | Investment Managers | Corporate Officer/Principal | |
Telios Pharmaceuticals, Inc.
 Telios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Integra LifeSciences Holdings Corp., Telios Pharmaceuticals, Inc. is a pharmaceutical company focused on research. The company is based in San Diego, CA. The company was founded by Iain David Dukes, Erkki Ruoslahti. Telios Pharmaceuticals was acquired by Integra LifeSciences Holdings Corp. on August 17, 1995 for $35 million. | Pharmaceuticals: Major | Founder | |
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Medical Specialties | Director/Board Member | |
Arrow International LLC
 Arrow International LLC Medical SpecialtiesHealth Technology Arrow International, Inc. manufactures disposable catheters and related products. Its products are used principally to access the central vascular system for administration of fluids, drugs, and blood products. The firm's products are also used for patient monitoring, diagnosis, and pain management. The company was founded in 1975 and is headquartered in Reading, PA. | Medical Specialties | Director/Board Member | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Reaction Biology Corp.
 Reaction Biology Corp. Miscellaneous Commercial ServicesCommercial Services Reaction Biology Corp. specializes in kinase and epigenetic HTS and profiling services. It offers radiolabeled biochemical assays available for multiple enzyme classes including: Kinase Assays, HMT Assays, and HDAC Assays. Its products include Methyltransferase, IDH proteins, Apoptosis, DNA Demethylation, Apoptosis and NQOs. The company was founded by Scott L. Diamond in 2001 and is headquartered in Malvern, PA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
GNC Corp.
 GNC Corp. Food RetailRetail Trade GNC Corp. retails natural and specialty foods. Its nutritional-supplements retail chain devoted solely to items such as vitamins and dietary products. The company also has stores within Rite Aid drugstores and makes Rite Aid private-label products. It was founded in 1935 and is headquartered in Pittsburgh, PA. | Food Retail | Director/Board Member | |
| NUPATHE INC | Medical Specialties | Director/Board Member Director/Board Member | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Analyst Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal | |
| University of Bath | College/University | Undergraduate Degree | |
| University of Oxford | College/University | Doctorate Degree | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Leeds | College/University | Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree | |
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Investment Committee Member Investment Committee Member | |
| The Financial Executives Institute | Corporate Officer/Principal | ||
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
| Rhodes University | College/University | Undergraduate Degree | |
| Glaxo, Inc. | Corporate Officer/Principal | ||
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Chairman | |
Corridor Pharmaceuticals, Inc.
 Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
BITOECH Consulting SAS
 BITOECH Consulting SAS Miscellaneous Commercial ServicesCommercial Services Part of Mabion SA, Biotech Consulting is a French company that provides business consulting services. The company is based in Cornier, France. | Miscellaneous Commercial Services | President | |
NeRRe Therapeutics Ltd.
 NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Medical Distributors | Director/Board Member | |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member | |
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member | |
| IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
Falcon Therapeutics, Inc.
 Falcon Therapeutics, Inc. BiotechnologyHealth Technology Falcon Therapeutics, Inc. provides biotechnology services. The company was founded by Karen J. Giroux, Anna M. Seal and Shawn Hingtgen and is headquartered in Chapel Hill, NC. | Biotechnology | Founder | |
GHO Capital Partners LLP
 GHO Capital Partners LLP Investment ManagersFinance GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
| THESEUS PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
Gwynant Therapeutics
 Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Gwynant Therapeutics develops new small molecules for oncology targets. | Pharmaceuticals: Major | Director/Board Member | |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Pharmaceuticals: Major | Founder | |
Viriom, Inc.
 Viriom, Inc. Miscellaneous Commercial ServicesCommercial Services Viriom, Inc. is a biotechnology company based in San Diego, CA. The company focuses on developing innovative therapies for infectious diseases, including HIV and COVID-19. Viriom's mission is to improve the lives of patients by providing effective and accessible treatments. Iain David Dukes has been the CEO of the company since 2019, leading the team in their efforts to advance the development of their pipeline and bring new therapies to market. | Miscellaneous Commercial Services | Chief Executive Officer | |
Trawsfynydd Therapeutics, Inc.
 Trawsfynydd Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Trawsfynydd Therapeutics, Inc. engages in discovering and developing antiviral medicines. The company is located in the US. | Miscellaneous Commercial Services | Founder |
Statistieken
Internationaal
| Verenigde Staten | 33 |
| Verenigd Koninkrijk | 8 |
| Frankrijk | 3 |
| Duitsland | 2 |
| China | 2 |
Sectoraal
| Health Technology | 24 |
| Commercial Services | 8 |
| Finance | 7 |
| Consumer Services | 7 |
| Retail Trade | 2 |
Operationeel
| Director/Board Member | 97 |
| Corporate Officer/Principal | 64 |
| President | 23 |
| Independent Dir/Board Member | 22 |
| Chairman | 21 |
Sterkste connecties
| Insiders | |
|---|---|
| Tadataka Yamada | 36 |
| Jim Datin | 34 |
| Iain Dukes | 30 |
| Richard Kollender | 30 |
| Mark Strobeck | 21 |
| David W Miller | 14 |
| Eric Lefebvre | 13 |
| Richard Wallace | 11 |
| Seth V. Hetherington | 9 |
| William Williams | 8 |
| Joseph Zimmermann | 8 |
| John Didsbury | 7 |
| Anna M. Seal | 7 |
| Michel Cimon | 7 |
| Jeff Brown | 6 |
- Beurs
- Insiders
- Michael H. Golden
- Bedrijfsconnecties
